SENORES PHARMACEUTICALS LIMITE (SENORES)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 9.59 11.86 19.82 35.33 28.76 36.81
YOY Revenue Growth % - - - - 199.93% 210.37%
Other Income 7.19 9.25 8.39 11.36 9.78 22.19
Total Income 16.78 21.11 28.21 46.69 38.54 59.00
Total Expenses + 8.53 18.21 24.62 39.04 35.02 46.31
Cost of Materials Consumed 1.83 2.81 1.40 1.00 3.78 18.36
Employee Benefit Expense 4.92 4.45 6.91 11.59 9.16 11.12
Other Expenses 1.78 3.41 6.92 10.59 8.16 5.65
Operating Profit 1.06 -6.35 -4.80 -3.71 -6.26 -9.50
OPM % 11.1% -53.5% -24.2% -10.5% -21.8% -25.8%
Profit Before Tax + 1.32 2.90 3.59 7.65 3.52 12.69
Tax Expense 0.25 0.88 0.89 1.22 0.87 4.21
Tax % 18.6% 30.3% 24.8% 15.9% 24.7% 33.2%
Profit After Tax 1.08 2.02 2.70 6.43 2.65 8.48
EPS (Basic) 0.32 0.39 0.59 1.40 1.98 1.84

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 38.54
YOY Revenue Growth % -
Other Income 21.99
Total Income 60.53
Total Expenses + 55.42
Cost of Materials Consumed 7.26
Employee Benefit Expense 18.25
Other Expenses 9.74
Operating Profit -16.88
OPM % -43.8%
Profit Before Exceptional 5.11
Exceptional Items 0.00
Profit Before Tax + 5.11
Tax Expense 1.42
Tax % 27.8%
Profit After Tax 3.69
EPS (Basic) 1.02

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 422.01
Property, Plant & Equipment 46.23
Capital Work in Progress 34.01
Non-Current Investments 104.38
Goodwill 0.00
Other Intangible Assets 0.02
Current Assets + 412.08
Inventories 8.66
Trade Receivables 25.69
Cash and Cash Equivalents 81.20
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 0.00
Equity Share Capital 46.05
Other Equity 661.91
Non-Current Liabilities 84.90
Current Liabilities 41.23
Total Liabilities 126.13

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities -20.40
Cash from Investing Activities -162.93
Cash from Financing Activities 532.62
Net Increase/Decrease in Cash 349.29